Senzime announced that Fukuda Denshi, is launching the first integrated TetraGraph module. The new NH-100 module, powered by Senzime's TetraGraph technology, is now marketed by Fukuda Denshi as an integrated solution for their bedside patient monitors to facilitate EMG-based neuromuscular monitoring in the operating room. The new Fukuda Denshi NH-100 module connects to Senzime's TetraSens disposable sensors.

The module is sold initially as an accessory in Japan to the Dynascope 1000 series DS-1200 system used for bedside patient monitoring of vital signs. Since 2016, Senzime has a license agreement with Fukuda Denshi, a leader in the patient monitoring market with annual sales exceeding USD 1 billion. By the agreement, Fukuda Denshi is granted exclusive rights to license and commercialize Senzime's TetraGraph technology in the Japanese market under its own brand.

Senzime generates revenues from Fukuda via manufacturing of certain products, product sales as well as royalty compensation based on actual sales in the Japanese market.